As mentioned earlier, Kontaki et al. declared in 2017 that CD33+CD15+CD14–HLA-DR–/low MDSCs isolated from IBD patients enhanced autologous T cell proliferation (49). The gene discussed is CD33; the disease is inflammatory bowel disease.